Wegovy Pill Just Changed: Why Lilly Stock Could Still Win
A new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Knowing when to prioritize financial planning over investment planning can significantly impact your financial success. Find the right balance for your goals.
25,526 articlesA new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
A prominent SaaS executive warns that AI could erode long-standing moats, while industry data show enduring protectio...
Two refining giants posted solid Q4 results, signaling a strong 2026 for the sector. The question on investors’ minds...
Bittensor TAO jumped close to 18% over a short window, signaling renewed momentum in AI-focused crypto. This article ...
Bitcoin faces renewed pressure as a large overnight repo operation from the Federal Reserve coincides with stress in ...
Bitcoin is trapped in a converging triangle as traders brace for a sharp breakout. A decisive move beyond key levels ...
Bitcoin traders are pricing a sharp pullback, with Polymarket data signaling a 75% chance BTC falls below 55,000 as m...
As markets wobble, investors turn to stalwarts with decades of dividend increases. Three dividend kings that have rai...
Rechat teams with Canva to streamline listing marketing, letting listing data flow into Canva and back with one click...
ARTY posted a 12-month gain of 28.3%, topping QQQ's 14.3% and SPY's 13.7%, as AI infrastructure exposure draws buyers...
Vistra reports record 2025 EBITDA and unveils a 2026 target that points to sustained growth. The company cites long-t...
Eos Energy Enterprises missed revenue expectations for Q4 2025, sparking a 39% one-day drop and renewed debate about ...